TRIM22 and osteosarcoma: TRIM22 inhibits osteosarcoma progression through destabilizing Nrf2 and thus activation of ROS/AMPK/mTOR/autophagy signalingTanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway